Metraipolis › archive › dc_740903c8be60

A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer — Europe PMC PMID:40928353

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40928353
DOI
10.1158/2767-9764.crc-25-0428
License (as archived)
solo-consultazione
Archived
2026-11-10T04:32:48.820Z
SHA-256 of the archived text
9d7c7daf954c6c3c373b455968b0d6b22ee7711d0d1bfdb47d594cf913796611
Stable URL of this page
https://metraipolis.com/documento/dc_740903c8be60

How to cite

A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer — Europe PMC PMID:40928353 — Europe PMC (en), https://europepmc.org/article/MED/40928353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_740903c8be60 (Metraipolis archive dc_740903c8be60, sha256 9d7c7daf954c6c3c373b455968b0d6b22ee7711d0d1bfdb47d594cf913796611)
BibTeX
@misc{dc740903c8be60,
  title = {A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer — Europe PMC PMID:40928353},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40928353},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_740903c8be60; sha256 9d7c7daf954c6c3c373b455968b0d6b22ee7711d0d1bfdb47d594cf913796611},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40928353. Agents can read the archived copy with the MCP tool read_document.